Skip to main content

and
  1. Article

    Open Access

    Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board

    In pancreatic cancer, systemic treatment options in addition to chemotherapy remain scarce, and so far only a small proportion of patients benefit from targeted therapies.

    Klara Dorman, Danmei Zhang, Kathrin Heinrich, Laurens Reeh, Lena Weiss in Targeted Oncology (2023)